Clinical Trials Browser

Interventional × Lenalidomide × Head & Neck × Clear all

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Adenocarcinoma, Follicular

NCT00287287 2020-06-12

REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas

Phase 2 Completed

25 enrolled 9 charts

Head & Neck

Thyroid Neoplasms

NCT01254617 2020-03-13

ADCC

Phase 1 Completed

24 enrolled

GastrointestinalHead & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Colonic Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms

NCT01166035 2010-07-20

TEXO

Phase 1/2 Unknown

20 enrolled

GastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms

Clinical Trials

Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer

REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas

ADCC

TEXO